vs
Immunovant, Inc.(IMVT)与PROVIDENT FINANCIAL HOLDINGS INC(PROV)财务数据对比。点击上方公司名可切换其他公司
PROVIDENT FINANCIAL HOLDINGS INC的季度营收约是Immunovant, Inc.的1.2倍($9.8M vs $8.4M),PROVIDENT FINANCIAL HOLDINGS INC净利率更高(14.6% vs -899.0%,领先913.6%),Immunovant, Inc.同比增速更快(140.7% vs 2.5%),PROVIDENT FINANCIAL HOLDINGS INC自由现金流更多($1.0M vs $-59.8M)
Immunovant是一家临床阶段生物制药企业,专注于开发用于治疗严重、罕见自身免疫性疾病及炎症性疾病的新型单克隆抗体疗法,其核心在研候选产品覆盖多种自身免疫适应症,面向全球医疗市场布局研发管线。
普罗维登特金融控股公司是一家银行控股企业,通过旗下全资子公司普罗维登特储蓄银行开展业务,为美国加利福尼亚州当地社区提供各类存款、住房抵押贷款、消费贷款、小微企业融资等零售及商业金融服务。
IMVT vs PROV — 直观对比
营收规模更大
PROV
是对方的1.2倍
$8.4M
营收增速更快
IMVT
高出138.3%
2.5%
净利率更高
PROV
高出913.6%
-899.0%
自由现金流更多
PROV
多$60.9M
$-59.8M
损益表 — Q4 FY2024 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $8.4M | $9.8M |
| 净利润 | $-75.3M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -896.2% | 20.8% |
| 净利率 | -899.0% | 14.6% |
| 营收同比 | 140.7% | 2.5% |
| 净利润同比 | -26.7% | 64.7% |
| 每股收益(稀释后) | $-0.50 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
IMVT
PROV
| Q4 25 | — | $9.8M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $9.8M | ||
| Q1 25 | — | $10.1M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | — | $9.5M | ||
| Q2 24 | — | $9.9M | ||
| Q1 24 | $8.4M | $9.4M |
净利润
IMVT
PROV
| Q4 25 | — | $1.4M | ||
| Q3 25 | — | $1.7M | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $872.0K | ||
| Q3 24 | — | $1.9M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | $-75.3M | $1.5M |
营业利润率
IMVT
PROV
| Q4 25 | — | 20.8% | ||
| Q3 25 | — | 28.1% | ||
| Q2 25 | — | 23.6% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | — | 12.7% | ||
| Q3 24 | — | 28.3% | ||
| Q2 24 | — | 27.8% | ||
| Q1 24 | -896.2% | 22.5% |
净利率
IMVT
PROV
| Q4 25 | — | 14.6% | ||
| Q3 25 | — | 17.3% | ||
| Q2 25 | — | 16.7% | ||
| Q1 25 | — | 18.4% | ||
| Q4 24 | — | 9.1% | ||
| Q3 24 | — | 20.0% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | -899.0% | 15.9% |
每股收益(稀释后)
IMVT
PROV
| Q4 25 | — | $0.22 | ||
| Q3 25 | — | $0.25 | ||
| Q2 25 | — | $0.24 | ||
| Q1 25 | — | $0.28 | ||
| Q4 24 | — | $0.13 | ||
| Q3 24 | — | $0.28 | ||
| Q2 24 | — | $0.28 | ||
| Q1 24 | $-0.50 | $0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $635.4M | $54.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $617.8M | $127.5M |
| 总资产 | $666.4M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
IMVT
PROV
| Q4 25 | — | $54.4M | ||
| Q3 25 | — | $49.4M | ||
| Q2 25 | — | $53.1M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | — | $45.5M | ||
| Q3 24 | — | $48.2M | ||
| Q2 24 | — | $51.4M | ||
| Q1 24 | $635.4M | $51.7M |
股东权益
IMVT
PROV
| Q4 25 | — | $127.5M | ||
| Q3 25 | — | $128.4M | ||
| Q2 25 | — | $128.5M | ||
| Q1 25 | — | $128.9M | ||
| Q4 24 | — | $128.6M | ||
| Q3 24 | — | $129.6M | ||
| Q2 24 | — | $129.9M | ||
| Q1 24 | $617.8M | $129.5M |
总资产
IMVT
PROV
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | $666.4M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-59.7M | $1.2M |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | $1.0M |
| 自由现金流率自由现金流/营收 | -714.4% | 10.5% |
| 资本支出强度资本支出/营收 | 1.8% | 1.9% |
| 现金转化率经营现金流/净利润 | — | 0.85× |
| 过去12个月自由现金流最近4个季度 | $-214.6M | $14.9M |
8季度趋势,按日历期对齐
经营现金流
IMVT
PROV
| Q4 25 | — | $1.2M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $8.7M | ||
| Q1 25 | — | $3.3M | ||
| Q4 24 | — | $324.0K | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | — | $5.7M | ||
| Q1 24 | $-59.7M | $3.0M |
自由现金流
IMVT
PROV
| Q4 25 | — | $1.0M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $8.2M | ||
| Q1 25 | — | $3.3M | ||
| Q4 24 | — | $307.0K | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | $4.1M | ||
| Q1 24 | $-59.8M | $2.6M |
自由现金流率
IMVT
PROV
| Q4 25 | — | 10.5% | ||
| Q3 25 | — | 25.2% | ||
| Q2 25 | — | 83.5% | ||
| Q1 25 | — | 32.5% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 41.3% | ||
| Q1 24 | -714.4% | 27.5% |
资本支出强度
IMVT
PROV
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 16.0% | ||
| Q1 24 | 1.8% | 4.2% |
现金转化率
IMVT
PROV
| Q4 25 | — | 0.85× | ||
| Q3 25 | — | 1.48× | ||
| Q2 25 | — | 5.34× | ||
| Q1 25 | — | 1.79× | ||
| Q4 24 | — | 0.37× | ||
| Q3 24 | — | 1.35× | ||
| Q2 24 | — | 2.91× | ||
| Q1 24 | — | 2.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图